Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest

Clinical trials sponsored by Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest, explained in plain language.

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 2

Chemo-Light trio offers hope for older lymphoma patients

Disease control Ongoing

This study tests a new drug combination for adults over 60 with aggressive B-cell lymphoma who cannot handle standard full-dose chemotherapy. The treatment uses three targeted drugs (rituximab, polatuzumab vedotin, and glofitamab) to attack the cancer while reducing side effects.…

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated May 01, 2026 19:27 UTC